CLRB Cellectar Biosciences, Inc.
Fundamentals / CIK 0001279704 / USDCellectar Biosciences, Inc. reported $29.74M in total assets and a net loss of $25.85M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CLRB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$26.78M Operating profit
-
Net Income FY 2025-$25.85M GAAP bottom line
-
Diluted EPS FY 2025-$1.48 Split-adjusted
-
Free Cash Flow FY 2025-$23.12M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$24.58M Total debt: $1.53M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development | $11.50M | $26.14M | $27.27M | $19.22M | $17.59M | $10.14M | $9.00M | $6.84M | $9.47M | $4.75M |
| Operating Income | -$22.98M | -$51.78M | -$38.96M | -$28.81M | -$24.13M | -$15.29M | -$14.18M | -$13.33M | -$13.60M | -$9.45M |
| EBITDA | -$22.77M | -$51.49M | -$38.77M | -$28.67M | -$23.98M | -$15.15M | -$14.05M | -$13.25M | -$12.05M | -$9.09M |
| Income Before Tax | -$21.79M | -$44.52M | -$42.83M | -$28.66M | -$24.12M | -- | -- | -- | -- | -- |
| Income Tax Expense | -- | $66K | -$60K | -$60K | -- | -- | $0 | $0 | $0 | $0 |
| Net Income | -$21.79M | -$44.58M | -$42.77M | -$28.60M | -$24.12M | -$15.09M | -$14.09M | -$13.24M | -$13.56M | -$6.18M |
| Basic EPS | -$8.35 | -$36.52 | -$105.11 | -$121.62 | -$130.63 | -$22.82 | -$55.26 | -$157.06 | -$321.32 | -$64.26 |
| Diluted EPS | -$8.35 | -$41.89 | -$105.11 | -$121.62 | -$130.63 | -$55.26 | -$55.26 | -$157.06 | -$321.32 | -$64.26 |
| Basic Shares Outstanding | 2.6M | 1.2M | 407.0K | 235.0K | 184.9K | 659.8K | 255.6K | 98.6K | 46.7K | 145.4K |
| Diluted Shares Outstanding | 2.6M | 1.2M | 407.0K | 235.0K | 184.9K | 659.8K | 255.6K | 98.6K | 46.7K | 145.4K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $5.44M | $4.56M | $3.01M | $3.16M | $2.52M | $2.39M | $3.43M | $6.21M |
| Operating Income | -$8.10M | -$7.20M | -$5.79M | -$5.69M | -$4.85M | -$6.04M | -$6.40M | -$12.74M |
| EBITDA | -- | -- | -- | -$5.64M | -$4.80M | -$5.98M | -$6.34M | -$12.68M |
| Net Income | -$7.97M | -$6.93M | -$5.65M | -$5.30M | -$4.44M | -$5.45M | -$6.60M | -$2.36M |
| Basic EPS | -$0.46 | -$0.57 | -$1.33 | -- | -$1.41 | -$3.39 | -$4.30 | -- |
| Diluted EPS | -$0.46 | -$0.57 | -$1.33 | -- | -$1.41 | -$3.39 | -$4.30 | -- |
| Basic Shares Outstanding | 17.5M | 12.2M | 4.2M | -- | 3.2M | 1.6M | 1.5M | -- |
| Diluted Shares Outstanding | 17.5M | 12.2M | 4.2M | -- | 3.2M | 1.6M | 1.5M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $13.20M | $23.29M | $9.56M | $19.87M | $35.70M | $57.17M | $10.61M | $13.26M | $10.01M | $11.44M |
| Cash & Short-Term Investments | $13.20M | $23.29M | $9.56M | $19.87M | $35.70M | $57.17M | $10.61M | $13.26M | $10.01M | $11.44M |
| Total Current Assets | $14.04M | $24.25M | $10.45M | $20.53M | $36.57M | $57.94M | $11.39M | $13.95M | $10.47M | $12.19M |
| Property, Plant & Equipment, Net | $549K | $757K | $1.09M | $419K | $344K | $356K | $435K | $543K | $245K | $1.44M |
| Goodwill | -- | -- | -- | -- | -- | -- | $0 | $0 | $1.68M | $1.68M |
| Long-Term Investments | -- | -- | $24K | $75K | $75K | $75K | $75K | $541K | $466K | -- |
| Other Non-Current Assets | $30K | $30K | $30K | $6.2K | $6.2K | $6.2K | $6.2K | $18K | $12K | $12K |
| Total Non-Current Assets | $940K | $1.22M | $1.62M | $1.06M | $630K | $720K | $865K | $1.10M | $2.40M | $3.13M |
| Total Assets | $14.98M | $25.47M | $12.08M | $21.59M | $37.20M | $58.66M | $12.25M | $15.05M | $12.87M | $15.32M |
| Accounts Payable | $1.44M | $4.11M | $5.62M | $2.56M | $1.42M | $1.43M | $1.28M | $612K | $933K | -- |
| Total Current Liabilities | $4.75M | $9.39M | $25.36M | $5.53M | $3.99M | $3.56M | $2.77M | $1.62M | $2.11M | $1.63M |
| Total Non-Current Liabilities | $309K | $410K | $494K | $553K | $166K | $302K | $422K | $171K | $2.2K | $152K |
| Total Liabilities | $5.06M | $9.80M | $25.85M | $6.08M | $4.16M | $3.86M | $3.19M | $1.79M | $2.12M | $1.78M |
| Total Debt (incl. Leases) | $410K | $494K | $553K | $604K | $302K | $422K | $528K | $2.2K | -- | -- |
| Common Stock | $42 | $15 | $207 | $94 | $61 | $454 | $94 | $47 | $16 | $104 |
| Retained Earnings | -$269.1M | -$247.3M | -$202.8M | -$179.5M | -$150.9M | -$126.8M | -$111.7M | -$97.59M | -$84.35M | -$70.79M |
| Total Stockholders' Equity | $8.54M | $14.29M | -$15.16M | $8.15M | $33.05M | $54.79M | $9.06M | $13.26M | $10.75M | $13.54M |
| Total Equity | $8.54M | $14.29M | -$15.16M | $8.15M | $33.05M | $54.79M | $9.06M | $13.26M | $10.75M | $13.54M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $24.58M | $33.99M | $8.35M | $13.20M | $12.55M | $11.04M | $13.91M | $23.29M |
| Cash & Short-Term Investments | $24.58M | $33.99M | $8.35M | $13.20M | $12.55M | $11.04M | $13.91M | $23.29M |
| Total Current Assets | $25.71M | $34.88M | $9.27M | $14.04M | $13.62M | $12.62M | $14.89M | $24.25M |
| Property, Plant & Equipment, Net | $269K | $304K | $340K | $549K | $595K | $648K | $701K | $757K |
| Other Non-Current Assets | $95K | $24K | $30K | $30K | $30K | $30K | $30K | $30K |
| Total Non-Current Assets | $4.03M | $1.76M | $1.85M | $940K | $1.01M | $1.08M | $1.15M | $1.22M |
| Total Assets | $29.74M | $36.64M | $11.12M | $14.98M | $14.63M | $13.70M | $16.04M | $25.47M |
| Accounts Payable | -- | -- | -- | $1.44M | -- | -- | -- | $4.11M |
| Total Current Liabilities | $5.80M | $5.24M | $4.87M | $4.75M | $4.91M | $5.87M | $6.02M | $9.39M |
| Total Non-Current Liabilities | $1.53M | $1.53M | $1.53M | $309K | $336K | $361K | $386K | $410K |
| Total Liabilities | $7.33M | $6.77M | $6.40M | $5.06M | $5.25M | $6.23M | $6.41M | $9.80M |
| Total Debt (incl. Leases) | $1.53M | $1.53M | $1.53M | $410K | $433K | $454K | $476K | $494K |
| Common Stock | $100 | $83 | $42 | $42 | $32 | $18 | $461 | $15 |
| Retained Earnings | -$289.7M | -$281.7M | -$274.8M | -$269.1M | -$263.8M | -$259.4M | -$253.9M | -$247.3M |
| Total Stockholders' Equity | $22.42M | $29.87M | $3.34M | $8.54M | $8.00M | $6.09M | $8.25M | $14.29M |
| Total Equity | $22.42M | $29.87M | $3.34M | $8.54M | $8.00M | $6.09M | $8.25M | $14.29M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$21.79M | -$44.58M | -$42.77M | -$28.60M | -$24.12M | -$15.09M | -$14.09M | -$13.24M | -$13.56M | -$6.18M |
| Depreciation & Amortization | $214K | $292K | $192K | $148K | $150K | $141K | $133K | $82K | $1.55M | $357K |
| Stock-Based Compensation | $2.26M | $4.27M | $2.41M | $1.45M | $1.12M | $468K | $867K | $721K | $759K | $529K |
| Operating Cash Flow | -$23.12M | -$47.58M | -$32.38M | -$25.22M | -$22.57M | -$13.93M | -$11.69M | -$11.44M | -$11.02M | -$8.28M |
| Capital Expenditure | -$5.9K | -$104K | -$864K | -$226K | -$141K | -$62K | -$25K | -$385K | -$347K | -$72K |
| Free Cash Flow | -$23.12M | -$47.69M | -$33.24M | -$25.45M | -$22.71M | -$14.00M | -$11.72M | -$11.83M | -$11.37M | -$8.35M |
| Investing Cash Flow | -$5.9K | -$104K | -$864K | -$226K | -$141K | -$62K | -$25K | -$330K | -$347K | -$72K |
| Common Stock Issued | -- | -- | -- | $9.61M | $35K | $59.72M | $9.02M | $9.08M | $4.91M | $12.36M |
| Financing Cash Flow | $13.03M | $61.41M | $22.94M | $9.61M | $1.25M | $60.55M | $9.02M | $15.02M | $9.93M | $15.94M |
| Net Change in Cash | -$10.09M | $13.72M | -$10.30M | -$15.84M | -$21.46M | $46.55M | -$2.70M | $3.25M | -$1.44M | $7.59M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$7.97M | -$6.93M | -$5.65M | -$5.30M | -$4.44M | -$5.45M | -$6.60M | -$2.36M |
| Depreciation & Amortization | -- | -- | -- | $49K | $52K | $56K | $56K | $69K |
| Stock-Based Compensation | $518K | $428K | $452K | $568K | $568K | $565K | $563K | $1.49M |
| Operating Cash Flow | -$9.41M | -$6.01M | -$4.85M | -$4.34M | -$4.28M | -$5.12M | -$9.38M | -$10.91M |
| Capital Expenditure | $0 | $0 | -$3.4K | -- | -- | -- | -- | -$61K |
| Free Cash Flow | -$9.41M | -$6.01M | -$4.85M | -- | -- | -- | -- | -$10.97M |
| Investing Cash Flow | $0 | $0 | -$3.4K | -- | -- | -- | -- | -$61K |
| Financing Cash Flow | -- | -- | -- | -- | -- | -- | -- | $0 |
| Net Change in Cash | -$9.41M | $25.65M | -$4.85M | $642K | $1.51M | -$2.86M | -$9.38M | -$10.97M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -255.2% | -311.9% | -- | -350.8% | -73.0% | -27.5% | -155.6% | -99.8% | -126.1% | -45.6% |
| Return on Assets (ROA) | -145.5% | -175.0% | -354.2% | -132.5% | -64.8% | -25.7% | -115.0% | -87.9% | -105.4% | -40.3% |
| Current Ratio | 2.96x | 2.58x | 0.41x | 3.71x | 9.16x | 16.26x | 4.11x | 8.60x | 4.95x | 7.47x |
| Quick Ratio | 2.78x | 2.48x | 0.38x | 3.59x | 8.95x | 16.04x | 3.83x | 8.17x | 4.73x | 7.01x |
| Debt to Equity | 0.05x | 0.03x | -- | 0.07x | 0.01x | 0.01x | 0.06x | 0.00x | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -115.3% | -74.7% | -624.9% | -255.2% | -235.7% | -477.8% | -297.4% | -311.9% |
| Return on Assets (ROA) | -86.9% | -60.9% | -187.4% | -145.5% | -128.9% | -212.3% | -153.0% | -175.0% |
| Current Ratio | 4.44x | 6.66x | 1.90x | 2.96x | 2.77x | 2.15x | 2.47x | 2.58x |
| Quick Ratio | 4.24x | 6.49x | 1.71x | 2.78x | 2.56x | 1.88x | 2.31x | 2.48x |
| Debt to Equity | 0.07x | 0.05x | 0.46x | 0.05x | 0.05x | 0.07x | 0.06x | 0.03x |